๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The use of prognostic factors in clinical trials

โœ Scribed by Harland N. Sather

Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
735 KB
Volume
58
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prognostic factors observed in current c
Prognostic factors observed in current clinical trials
โœ F. Andrew Dorr ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 586 KB

Adjuvant therapy of breast cancer has evolved over the past 15 years from an interesting clinical experiment to the standard of care for many patients. The toxicities of different treatments vary from those with minimal side effects, such as tamoxifen, to those with potentially lifethreatening side

Prognostic factors for survival in patie
Prognostic factors for survival in patients treated in phase I clinical trials
โœ Linda Janisch; Rosemarie Mick; Richard L. Schilsky; Nicholas J. Vogelzang; Sheil ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 720 KB

Background. Patients with advanced or metastatic cancer treated in Phase I clinical trials are considered to have a poor prognosis. Survival from first treatment in a Phase I trial was determined for 349 patients. Univariate and multivariate survival analyses were performed to determine whether pote

AN ALTERNATIVE TO THE USE OF TWO-SIDED T
AN ALTERNATIVE TO THE USE OF TWO-SIDED TESTS IN CLINICAL TRIALS
โœ CHARLES W. DUNNETT; MICHAEL GENT ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 700 KB

There is a controversy in the literature concerning the use of one-and two-sided tests in clinical trials. Some contend that, when the research question relates to improved efficacy or safety, that is, the expected change is in one direction only, the hypothesis test should reflect this by being one